Picture of Faeth Therapeutics, logo

FTH Faeth Therapeutics, News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Sensei Biotherapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

* Sensei Biotherapeutics Inc  SNSE.OQ  reported a quarterly
adjusted loss of 29 cents​​ per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of -28 cents.  The mean expectation of
four analysts for the quarter was for a loss of 31 cents per
share. Wall Street expected results to range from -33 cents
to -29 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Sensei Biotherapeutics Inc's reported EPS for the quarter
was a
loss of 29 cents​.
    * The company reported a quarterly loss of $7.25 million.
    * Sensei Biotherapeutics Inc shares had fallen by 11.1% this
quarter and lost 23.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Sensei
Biotherapeutics Inc is 4.00 
This summary was machine generated from LSEG data November 14 at
08:58 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.31          -0.29          Beat
 Jun. 30 2024      -0.29          -0.28          Beat
 Mar. 31 2024      -0.27          -0.32          Missed
 Dec. 31 2023      -0.31          -0.30          Beat

Recent news on Faeth Therapeutics,

See all news